metadata toggle
Loading image navigation...
No image index could be found for this publication.
Close this Panel
Significant changes
Change titleChange detailChange dateDatasheetCreated by
Bovalto Respi IntranasalAddition of a 1-dose presentation impacting Section 5.4. Update to new SPC template (QRD v9) - formatting change to Section 3.6 (Adverse events), change to Section 3.10 (Overdose), change to Section 5.5 (Disposal). Previous UK licence split to GB and NI licences. This is the NI datasheet with the new MA number.30 December 2022Bovalto Respi Intranasal (NI)boehringer-everard
Change titleChange detailChange dateDatasheetCreated by